Mirum Pharmaceuticals Inc Aktie News

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

Biotech stock Mirum Pharmaceuticals has rocketed 236% since its IPO in 2019. Shares are near a buy point after earnings.

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

FOSTER CITY, Calif.--(BUSINESS WIRE)---- $MIRM #leadership--Mirum Pharmaceuticals Appoints Doug Sheehy, JD as Chief Legal Officer.

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and orphan diseases, today announced that it will participate in the following upcoming investor conferences: 3rd Annual H.C. Wainwright BioConnect Investor Conference ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

FOSTER CITY, Calif.--(BUSINESS WIRE)---- $mirm #easl2025--Volixibat Data from Mirum's VANTAGE PBC Study Showcased at EASL.

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Andrew McKibben - SVP, Strategic Finance and IR Chris Peetz - CEO Peter Radovich - President and COO Eric Bjerkholt - CFO Conference Call Participants Gavin Clark-Gartner - Evercore Jessica Fye - JPMorgan Selena Zhang - Morgan Stanley Ryan McElroy - Leerink Partners David Lebo...